Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
We have evidence that second-to-market competition is reaching patients more slowly - if it reaches them at all - when it comes to drugs targeting rarer diseases. This reduced competition is a factor in rising drug costs, and challenges patients face accessing critical medicines.
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.